Your browser doesn't support javascript.
loading
Pharmacokinetics, Tolerability, and Bacteriological Response of Rifampin Administered at 600, 900, and 1,200 Milligrams Daily in Patients with Pulmonary Tuberculosis.
Aarnoutse, R E; Kibiki, G S; Reither, K; Semvua, H H; Haraka, F; Mtabho, C M; Mpagama, S G; van den Boogaard, J; Sumari-de Boer, I M; Magis-Escurra, C; Wattenberg, M; Logger, J G M; Te Brake, L H M; Hoelscher, M; Gillespie, S H; Colbers, A; Phillips, P P J; Plemper van Balen, G; Boeree, M J.
Afiliación
  • Aarnoutse RE; Radboud University Medical Center, Department of Pharmacy, Nijmegen, the Netherlands.
  • Kibiki GS; Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Reither K; Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Centre, Tumaini University, Moshi, Tanzania.
  • Semvua HH; Swiss Tropical and Public Health Institute, Basel, Switzerland.
  • Haraka F; University of Basel, Basel, Switzerland.
  • Mtabho CM; Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Centre, Tumaini University, Moshi, Tanzania.
  • Mpagama SG; Ifakara Health Institute, Bagamoyo, Tanzania.
  • van den Boogaard J; Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Centre, Tumaini University, Moshi, Tanzania.
  • Sumari-de Boer IM; Kibong'oto National Tuberculosis Hospital, Sanya Juu, Tanzania.
  • Magis-Escurra C; Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Centre, Tumaini University, Moshi, Tanzania.
  • Wattenberg M; Radboud University Medical Center, Department of Lung Diseases, Nijmegen, the Netherlands.
  • Logger JGM; Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Centre, Tumaini University, Moshi, Tanzania.
  • Te Brake LHM; Radboud University Medical Center, Department of Internal Medicine, Nijmegen, the Netherlands.
  • Hoelscher M; Radboud University Medical Center, Department of Lung Diseases, Nijmegen, the Netherlands.
  • Gillespie SH; Radboud University Medical Center, Department of Medical Microbiology, Nijmegen, the Netherlands.
  • Colbers A; Radboud University Medical Center, Department of Pharmacy, Nijmegen, the Netherlands.
  • Phillips PPJ; Radboud University Medical Center, Department of Pharmacy, Nijmegen, the Netherlands Lindsey.teBrake@radboudumc.nl.
  • Plemper van Balen G; Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Boeree MJ; Radboud University Medical Center, Department of Lung Diseases, Nijmegen, the Netherlands.
Antimicrob Agents Chemother ; 61(11)2017 11.
Article en En | MEDLINE | ID: mdl-28827417
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Rifampin / Tuberculosis Pulmonar / Antibióticos Antituberculosos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Antimicrob Agents Chemother Año: 2017 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Rifampin / Tuberculosis Pulmonar / Antibióticos Antituberculosos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Antimicrob Agents Chemother Año: 2017 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos